Y. Yazdanpanah

Most-cited papers

1. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

   Pierre-Louis Gilles Arthur Xavier Olivier Matthieu Raphael Phil Tharaux Pialoux Pavot Mariette Hermine Resche-Rigo, P. Tharaux, Gilles Pialoux, Arthur Pavot +496 more

   2021The Lancet Respiratory Medicine243 citations Open access

   Semantic Scholar

   Save

2. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

   N. Néant, G. Lingas, Q. Le Hingrat, J. Ghosn +30 more

   2021Proceedings of the National Academy of Sciences of the United States of America214 citations Open access

   Semantic Scholar

   Save

3. Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study

   M. Mailhe, Anne-Lise Beaumont, M. Thy, D. le Pluart +18 more

   2022Clinical Microbiology and Infection205 citations Open access

   Semantic Scholar

   Save

4. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

   Y. Lévy, A. Wiedemann, B. Hejblum, M. Durand +19 more

   2021iScience143 citations Open access

   Semantic Scholar

   Save

5. Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection

   H. Tarhini, A. Recoing, A. Bridier-Nahmias, M. Rahi +11 more

   2021Journal of Infectious Diseases105 citations Open access

   Semantic Scholar

   Save

6. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

   F. Ader, N. Peiffer-Smadja, J. Poissy, M. Bouscambert-Duchamp +54 more

   2021Clinical Microbiology and Infection88 citations Open access

   Semantic Scholar

   Save

7. Effects of remdesivir in hospitalized patients with COVID-19: Systematic review and individual patient data meta-analysis of randomized trials

   A. Amstutz, B. Speich, F. Mentré, C. Rueegg +31 more

   2023The Lancet Respiratory Medicine84 citations Open access

   Semantic Scholar

   Save

8. After 2 years of the COVID-19 pandemic, translating One Health into action is urgent

   T. Lefrançois, D. Malvy, L. Atlani-Duault, D. Benamouzig +4 more

   2022The Lancet83 citations Open access

   Semantic Scholar

   Save

9. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

   P. Sax, J. Arribas, C. Orkin, A. Lazzarin +11 more

   2023EClinicalMedicine81 citations Open access

   Semantic Scholar

   Save

10. Challenges of data sharing in European Covid-19 projects: A learning opportunity for advancing pandemic preparedness and response

    E. Tacconelli, A. Górska, E. Carrara, R. Davis +14 more

    2022The Lancet Regional Health - Europe64 citations Open access

    Semantic Scholar

    Save

11. Breakthrough Infections after Postexposure Vaccination against Mpox.

    Michael Thy, N. Peiffer-Smadja, M. Mailhe, Laura Kramer +23 more

    2022New England Journal of Medicine58 citations Open access

    Semantic Scholar

    Save

12. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.

    O. Ogbuagu, S. Segal-maurer, W. Ratanasuwan, A. Avihingsanon +11 more

    2023The Lancet HIV56 citations

    Semantic Scholar

    Save

13. Screening and vaccination against COVID-19 to minimise school closure: a modelling study

    E. Colosi, G. Bassignana, Diego Andrés Contreras, Canelle Poirier +7 more

    2022Lancet. Infectious Diseases (Print)55 citations Open access

    Semantic Scholar

    Save

14. Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

    M. Kieh, L. Richert, A. Beavogui, B. Grund +32 more

    2022New England Journal of Medicine50 citations Open access

    Semantic Scholar

    Save

15. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2

    N. Peiffer-Smadja, A. Bridier-Nahmias, V. Ferré, C. Charpentier +9 more

    2021Viruses47 citations Open access

    Semantic Scholar

    Save

16. A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial.

    R. Landman, P. de Truchis, L. Assoumou, S. Lambert +18 more

    2022The Lancet HIV41 citations Open access

    Semantic Scholar

    Save

17. A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab

    M. Hentzien, B. Autran, L. Piroth, Y. Yazdanpanah +1 more

    2022Lancet. Infectious Diseases (Print)40 citations Open access

    Semantic Scholar

    Save

18. Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.

    J. Molina, Y. Yazdanpanah, Alejandro Afani Saud, Christopher J Bettacchi +10 more

    2021The Lancet HIV38 citations

    Semantic Scholar

    Save

19. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

    Xavier Olivier Pierre-Louis Matthieu Raphael Philippe Ser Mariette Hermine Tharaux Resche-Rigon Porcher Rava, Xavier Mariette, O. Hermine, P. Tharaux +496 more

    2021The Lancet Rheumatology38 citations Open access

    Semantic Scholar

    Save

20. Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19

    M. Peyneau, V. Granger, P. Wicky, D. Khelifi-Touhami +9 more

    2022Scientific Reports37 citations Open access

    Semantic Scholar

    Save

21. The value of open-source clinical science in pandemic response: lessons from ISARIC

    Ali Sheryl Ann Nurul Najmee Ryuzo Laurent Lara Subhash Abbas Abdukahil Abdulkadir Abe Abel Absil Acharya , A. Abbas, S. Abdukahil, Nurul Najmee Abdulkadir +496 more

    2021Lancet. Infectious Diseases (Print)34 citations Open access

    Semantic Scholar

    Save

22. Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

    M. Trøseid, J. Arribas, L. Assoumou, A. R. Holten +411 more

    2023Critical Care29 citations Open access

    Semantic Scholar

    Save

23. Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study

    C. Durand, Eric Douriez, Aude Chappuis, F. Poulain +4 more

    2022Journal of Pharmaceutical Policy and Practice29 citations Open access

    Semantic Scholar

    Save

24. A Healthcare-Associated Infection With Monkeypox Virus of a Healthcare Worker During the 2022 Outbreak

    D. le Pluart, Mirabelle Ruyer-Thompson, V. Ferré, M. Mailhe +6 more

    2022Open Forum Infectious Diseases25 citations Open access

    Semantic Scholar

    Save

25. Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study

    D. Bouzid, Q. Le Hingrat, Florian Salipante, V. Ferré +10 more

    2023Clinical Microbiology and Infection24 citations Open access

    Semantic Scholar

    Save

26. Myocarditis in monkeypox-infected patients: a case series

    M. Dumont, Thomas Guilhou, M. Gérin, Guillemette Frémont-Goudot +7 more

    2022Clinical Microbiology and Infection22 citations Open access

    Semantic Scholar

    Save

27. Increased linezolid plasma concentrations are associated with the development of severe toxicity in MDR-TB treatment.

    Johannes Eimer, M. Fréchet-Jachym, Damien Le Dû, E. Caumes +9 more

    2022Clinical Infectious Diseases22 citations Open access

    Semantic Scholar

    Save

28. Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine

    J. Molina, Y. Yazdanpanah, Alejandro Afani Saud, Christopher J Bettacchi +9 more

    2021Journal of Acquired Immune Deficiency Syndromes22 citations Open access

    Semantic Scholar

    Save

29. Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France

    P. Bosetti, Cécile Tran Kiem, A. Andronico, V. Colizza +4 more

    2022BMC Medicine21 citations Open access

    Semantic Scholar

    Save

30. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial

    G. Lingas, N. Néant, A. Gaymard, D. Belhadi +16 more

    2022Journal of Antimicrobial Chemotherapy19 citations Open access

    Semantic Scholar

    Save

31. Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years

    E. Alidjinou, J. Demaret, B. Corroyer-Simovic, J. Labreuche +21 more

    2022The Lancet Regional Health - Europe19 citations Open access

    Semantic Scholar

    Save

32. Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019

    Y. Kherabi, M. Fréchet-Jachym, C. Rioux, Y. Yazdanpanah +4 more

    2022Emerging Infectious Diseases17 citations Open access

    Semantic Scholar

    Save

33. Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March–May 2020)

    M. Husain, A. Rachline, A. Cousien, S. Rolland +9 more

    2021Clinical Microbiology and Infection17 citations Open access

    Semantic Scholar

    Save

34. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.

    Chloé De Broucker, A. Plessier, I. Ollivier-Hourmand, S. Dharancy +17 more

    2021Journal of Hepatology17 citations Open access

    Semantic Scholar

    Save

35. Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial

    F. Ader, N. Peiffer-Smadja, J. Poissy, M. Bouscambert-Duchamp +53 more

    2021medRxiv15 citations Open access

    Semantic Scholar

    Save

36. Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines.

    E. Lhomme, A. Wiedemann, A. Ayouba, Safaa Ben-Farhat +14 more

    2026New England Journal of Medicine14 citations

    Semantic Scholar

    Save

37. Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1

    A. Bachelard, A. Sautereau, M. Digumber, V. Isernia +6 more

    2022International Journal of Infectious Diseases14 citations Open access

    Semantic Scholar

    Save

38. Adaptation and Response of a Major Parisian Referral Hospital to the COVID-19 Surge: A Qualitative Study

    Fanny Chabrol, L. Traverson, Ren-You Hou, Lisa Chotard +7 more

    2023Health systems and reform13 citations Open access

    Semantic Scholar

    Save

39. Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017

    Mathieu Castry, A. Cousien, J. Bellet, K. Champenois +5 more

    2021Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin12 citations Open access

    Semantic Scholar

    Save

40. Self-testing and vaccination against COVID-19 to minimize school closure

    Elisabetta Colosi, Giulia Bassignana, Diego Andrés Contreras, Canelle Poirier +6 more

    2021medRxiv12 citations Open access

    Semantic Scholar

    Save

41. Histological features associated with Human Monkeypox Virus Infection in 2022 outbreak in a non-endemic country.

    F. Chalali, M. Merlant, Audrey Truong, J. Ghosn +12 more

    2022Clinical Infectious Diseases11 citations

    Semantic Scholar

    Save

42. COVID-19 vaccines: A race against time

    N. Peiffer-Smadja, S. Rozencwajg, Y. Kherabi, Y. Yazdanpanah +1 more

    2021Anaesthesia Critical Care & Pain Medicine11 citations Open access

    Semantic Scholar

    Save

43. Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years

    C. Durier, L. Ninove, M. Lefebvre, Anne Radenne +82 more

    2022Scientific Reports10 citations Open access

    Semantic Scholar

    Save

44. A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France

    P. Bosetti, C. T. Kiem, A. Andronico, J. Paireau +8 more

    202110 citations

    Semantic Scholar

    Save

45. Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB)

    N. de Castro, F. Méchaï, D. Bachelet, A. Canestri +10 more

    2022Open Forum Infectious Diseases8 citations Open access

    Semantic Scholar

    Save

46. Low to undetectable Omicron BQ.1.1 neutralization by patient's sera a month after initiation of AZD7442 600mg.

    F. Touret, G. Martin-Blondel, X. D. de Lamballerie, A. Dupont +30 more

    2023Journal of Infection7 citations

    Semantic Scholar

    Save

47. Tuberculosis treatment outcomes among precarious patients in france.

    F. Méchaï, D. Bachelet, L. Han, M. Dubert +11 more

    2022Infectious Diseases Now7 citations Open access

    Semantic Scholar

    Save

48. Low serum neutralization of Omicron variants a month after AZD7442 prophylaxis initiation

    X. D. de Lamballerie, G. Martin-Blondel, A. Dupont, J. Izopet +26 more

    2022Journal of Infection7 citations Open access

    Semantic Scholar

    Save

49. Corrigendum to ‘detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives’

    Q. Le Hingrat, B. Visseaux, C. Laouénan, S. Tubiana +14 more

    2021Clinical Microbiology and Infection7 citations Open access

    Semantic Scholar

    Save

50. Health status and health care trajectory of vulnerable asylum seekers hosted in a French Reception Center.

    Marie Cortier, Clémentine de La Porte, E. Papot, A. Goudjo +6 more

    2021Travel Medicine and Infectious Disease7 citations Open access

    Semantic Scholar

    Save